83
Participants
Start Date
December 24, 2013
Primary Completion Date
June 1, 2015
Study Completion Date
August 3, 2016
nab-paclitaxel
nab-paclitaxel at 125 mg/m\^2, by IV infusion over 30 to 40 minutes (maximum infusion time not to exceed 40 minutes)
Gemcitabine
Gemcitabine at 1000 mg/m\^2 IV infusion over 30 to 40 minutes given once weekly for 3 weeks (Days 1, 8 and 15) followed by a week of rest (28 day cycle).
307 Hospital of Chinese PLA, Beijing
Beijing Cancer Hospital, Beijing, PR
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang
Peking Union Medical College Hospital, Beijing
The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, Zhejiang
Chinese PLA General Hospital, Beijing
Harbin Medical University Tumor Hospital, Harbin, Heilongjiang
Fudan University Shanghai Cancer Center, Shanghai
Shanghai First People's Hospital, Shanghai
Jiangsu Province Hospital The First Hospital affiliated with Nanjing Medical University, Nanjing
Zhejiang Cancer Hospital, Hangzhou
Tianjin Medical University Cancer Institute and Hospital, Tianjin
Sun Yat-sen University Cancer Center, Guangzhou
Xijing Hospital, Xi'an
Henan Cancer Hospital, Zhengzhou
Lead Sponsor
Celgene
INDUSTRY